ATE370160T1 - Peptide mit affinität zu gp120, und ihre verwendungen - Google Patents
Peptide mit affinität zu gp120, und ihre verwendungenInfo
- Publication number
- ATE370160T1 ATE370160T1 AT02700342T AT02700342T ATE370160T1 AT E370160 T1 ATE370160 T1 AT E370160T1 AT 02700342 T AT02700342 T AT 02700342T AT 02700342 T AT02700342 T AT 02700342T AT E370160 T1 ATE370160 T1 AT E370160T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- affinity
- specificity
- family
- producing
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100893A FR2819809B1 (fr) | 2001-01-23 | 2001-01-23 | Peptides presentant un affinite pour la proteine virale gp120, et utilisation de ces peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE370160T1 true ATE370160T1 (de) | 2007-09-15 |
Family
ID=8859145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02700342T ATE370160T1 (de) | 2001-01-23 | 2002-01-21 | Peptide mit affinität zu gp120, und ihre verwendungen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7374875B2 (de) |
| EP (1) | EP1368372B1 (de) |
| JP (1) | JP4307838B2 (de) |
| KR (1) | KR100910199B1 (de) |
| CN (1) | CN1304421C (de) |
| AT (1) | ATE370160T1 (de) |
| AU (1) | AU2002233424B2 (de) |
| CA (1) | CA2435097A1 (de) |
| DE (1) | DE60221805T2 (de) |
| DK (1) | DK1368372T3 (de) |
| ES (1) | ES2291439T3 (de) |
| FR (1) | FR2819809B1 (de) |
| IL (2) | IL156799A0 (de) |
| MX (1) | MXPA03006263A (de) |
| WO (1) | WO2002059146A2 (de) |
| ZA (1) | ZA200305576B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040076640A1 (en) * | 1999-02-15 | 2004-04-22 | Institut De Recherche Pour Le Developement (I.R.D) | Vaccine compositions against infectious pathologies for mammals |
| FR2838649B1 (fr) * | 2002-04-19 | 2006-01-13 | Commissariat Energie Atomique | Composition anti-vih, procede de fabrication et medicament |
| WO2007020886A1 (ja) | 2005-08-16 | 2007-02-22 | Sanyo Chemical Industries, Ltd. | タンパク質のリフォールディング剤およびリフォールディング方法 |
| JP4625433B2 (ja) * | 2005-08-16 | 2011-02-02 | 三洋化成工業株式会社 | タンパク質のリフォールディング剤およびリフォールディング方法 |
| WO2007144685A1 (en) | 2006-06-13 | 2007-12-21 | Commissariat A L'energie Atomique | Cd4 mimic peptides and their uses |
| FR2904627B1 (fr) * | 2006-08-04 | 2008-11-07 | Pasteur Institut | Nouveaux peptides actives, purifies et isoles, derives du recepteur cd4 (mini-cd4) et leur procece de preparation |
| JP2008209378A (ja) * | 2007-01-31 | 2008-09-11 | Fujifilm Corp | バイオセンサー基板 |
| EP2087911A1 (de) * | 2008-02-06 | 2009-08-12 | Institut Pasteur | Konjugierte Moleküle mit einem Peptid aus dem mit einem Polyanion gekoppelten CD4-Rezeptor zur Behandlung von AIDS |
| CN115322253A (zh) | 2014-03-20 | 2022-11-11 | 百时美施贵宝公司 | 稳定化的基于纤连蛋白的支架分子 |
| CN110461861B (zh) * | 2016-11-09 | 2024-11-15 | 南洋理工大学 | 人参肽和人参肽类似肽的制备和利用 |
| CN108640977A (zh) * | 2018-06-18 | 2018-10-12 | 上海大学 | 特异性结合HIV上包膜糖蛋白gp120的多肽及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684622A (en) * | 1984-11-21 | 1987-08-04 | Smithkline Beckman Corporation | Compositions and methods for producing vasodilation and antioxytocic activity |
| US4599324A (en) * | 1984-11-21 | 1986-07-08 | Smithkline Beckman Corporation | V1-vasopressin antagonists |
| US4721704A (en) * | 1986-05-09 | 1988-01-26 | Peninsula Laboratories, Inc. | Potent synthetic atrial peptide analogs |
-
2001
- 2001-01-23 FR FR0100893A patent/FR2819809B1/fr not_active Expired - Fee Related
-
2002
- 2002-01-21 WO PCT/FR2002/000227 patent/WO2002059146A2/fr not_active Ceased
- 2002-01-21 AU AU2002233424A patent/AU2002233424B2/en not_active Ceased
- 2002-01-21 JP JP2002559448A patent/JP4307838B2/ja not_active Expired - Fee Related
- 2002-01-21 MX MXPA03006263A patent/MXPA03006263A/es active IP Right Grant
- 2002-01-21 ES ES02700342T patent/ES2291439T3/es not_active Expired - Lifetime
- 2002-01-21 DK DK02700342T patent/DK1368372T3/da active
- 2002-01-21 KR KR1020037009627A patent/KR100910199B1/ko not_active Expired - Fee Related
- 2002-01-21 AT AT02700342T patent/ATE370160T1/de not_active IP Right Cessation
- 2002-01-21 DE DE60221805T patent/DE60221805T2/de not_active Expired - Lifetime
- 2002-01-21 IL IL15679902A patent/IL156799A0/xx unknown
- 2002-01-21 CN CNB028039831A patent/CN1304421C/zh not_active Expired - Fee Related
- 2002-01-21 EP EP02700342A patent/EP1368372B1/de not_active Expired - Lifetime
- 2002-01-21 US US10/466,835 patent/US7374875B2/en not_active Expired - Fee Related
- 2002-01-21 CA CA002435097A patent/CA2435097A1/en not_active Abandoned
-
2003
- 2003-07-06 IL IL156799A patent/IL156799A/en not_active IP Right Cessation
- 2003-07-18 ZA ZA200305576A patent/ZA200305576B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2819809B1 (fr) | 2003-05-16 |
| JP4307838B2 (ja) | 2009-08-05 |
| KR100910199B1 (ko) | 2009-07-30 |
| AU2002233424B2 (en) | 2006-01-05 |
| WO2002059146A3 (fr) | 2002-12-05 |
| DE60221805D1 (de) | 2007-09-27 |
| KR20040011454A (ko) | 2004-02-05 |
| JP2004535366A (ja) | 2004-11-25 |
| IL156799A (en) | 2010-04-15 |
| CN1487951A (zh) | 2004-04-07 |
| CN1304421C (zh) | 2007-03-14 |
| MXPA03006263A (es) | 2005-04-29 |
| ZA200305576B (en) | 2004-07-21 |
| CA2435097A1 (en) | 2002-08-01 |
| IL156799A0 (en) | 2004-02-08 |
| ES2291439T3 (es) | 2008-03-01 |
| WO2002059146A2 (fr) | 2002-08-01 |
| US20060121538A1 (en) | 2006-06-08 |
| FR2819809A1 (fr) | 2002-07-26 |
| DE60221805T2 (de) | 2008-05-15 |
| US7374875B2 (en) | 2008-05-20 |
| EP1368372B1 (de) | 2007-08-15 |
| EP1368372A2 (de) | 2003-12-10 |
| DK1368372T3 (da) | 2008-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28641A1 (es) | Anticuerpos | |
| WO2002074795A3 (en) | Oligomeric complexes of chimeric proteins with enhanced immunogenic potential | |
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| MXPA02004666A (es) | Gelatinas recombinantes. | |
| UA85536C2 (en) | Viral antigens | |
| AT500379B1 (de) | Tau-proteine | |
| ATE380822T1 (de) | Funf-helix protein | |
| ATE496063T1 (de) | Hybrid und tandemproteine von neisseria sp | |
| YU1402A (sh) | Hibridni polipeptidi sa pojačanim farmakokinetičkim osobinama | |
| IL157446A0 (en) | Increased recovery of active proteins | |
| WO2002038592A3 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| ATE370160T1 (de) | Peptide mit affinität zu gp120, und ihre verwendungen | |
| ATE330017T1 (de) | Kallikrein gen | |
| WO2003087138A3 (en) | Methods for identifying polypeptide factors interacting with rna | |
| EP1530579A4 (de) | Rekombinante antikörper sowie zusammensetzungen und verfahren zu deren herstellung und verwendung | |
| WO2002042412A3 (en) | Protease inhibitors and their pharmaceutical uses | |
| AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
| EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
| DE69938130D1 (de) | Neue peptide | |
| DE50002164D1 (de) | Peptide zur inhibierung von hpv e6-proteinen | |
| WO2002000686A3 (en) | Bioelastomer nanomachines and biosensors | |
| GB0221169D0 (en) | Crystal | |
| EA200400393A1 (ru) | Антитела против каспазы-8, их получение и применение | |
| WO2000058438A3 (en) | Conformationally constrained peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |